menu search

Bioxcel therapeutics to report third quarter 2023 financial results on november 14, 2023

NEW HAVEN, Conn., Oct. 31, 2023 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intel...

October 31, 2023, 11:00 am

Neumora therapeutics to participate in upcoming conferences in november

WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining <...

October 30, 2023, 7:00 am

Medtronic stock is simply too cheap to ignore

Medtronic is a global medical technology company specializing in various medical devices. The company's revenues are well distributed among different ...

October 29, 2023, 5:07 am

Why abbvie stock fell today

AbbVie stock fell today despite easily exceeding estimates for its third quarter. Revenue declines across AbbVie's immunology, oncology, and aesthetic...

October 27, 2023, 3:06 pm

Seelos therapeutics to present a poster on sls-005 in alzheimer's disease at neuroscience 2023

-SLS-005 induces autophagy to reduce mutant protein aggregates, and is currently being studied in Alzheimer's disease, Huntington's disease, Amyotroph...

October 27, 2023, 8:11 am

Cognitive drivers of crypto investments: a neurofinance exploration of bitcoin

Amidst the dynamic evolution of the financial realm, an intriguing convergence of neuroscience and inve...

October 16, 2023, 4:29 am

Cerevel therapeutics to report third quarter 2023 financial results and business updates on wednesday, november 1, 2023

CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain...

October 13, 2023, 10:30 am

Cerevel therapeutics to report third quarter 2023 financial results and business updates on wednesday, november 1, 2023

CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain ...

October 13, 2023, 6:30 am

Cerevel therapeutics announces pricing of $450 million public offering of common stock

CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) — Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE), a company dedicated to unraveling the mysteri...

October 12, 2023, 2:45 am

Vigil neuroscience to present at jefferies inaugural biotech cns/neuro summit

WATERTOWN, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Vigil neuroscience, Inc. (Nasdaq: VIGL), a clinical...

October 5, 2023, 4:01 pm

Vigil neuroscience: interesting early data, wait for phase 2

Vigil neuroscience is developing medicines for neurodegenerative diseases by restoring microglial funct...

September 18, 2023, 2:38 pm

Neumora therapeutics announces pricing of initial public offering

WATERTOWN, Mass., Sept. 14, 2023 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc. (“Neumora”), a clinical-stage biopharmaceutical company redefinin...

September 15, 2023, 12:49 am

Helius medical technologies to present at the 2023 interdisciplinary association of functional neuroscience and rehabilitation conference

-- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation techno...

September 13, 2023, 7:05 am

Vigil neuroscience to present at 2023 morgan stanley global healthcare conference

WATERTOWN, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) — Vigil neuroscience, Inc. (Nasdaq: VIGL), a clinic...

September 8, 2023, 11:05 am

Promis neurosciences to present at the h.c. wainwright 25th annual global investment conference

TORONTO, Ontario and CAMBRIDGE, Massachusetts, Sept. 06, 2023 (GLOBE NEWSWIRE) -- ProMIS neurosciences ...

September 6, 2023, 12:18 pm

Abbvie: balance is everything

AbbVie's future growth depends on improving its balance of drugs offered, in contrast to its Humira-dependent first decade. Skyrizi and Rinvoq should ...

September 4, 2023, 1:12 am

Cerevance announces presentation at the 22nd society of chemical industry / royal society of chemistry medicinal chemistry symposium

BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel, pre...

August 31, 2023, 12:30 pm

Eagle pharmaceuticals to present byfavo® (remimazolam) for injection abstract at prestigious society for neuroscience in anesthesiology and critical care (snacc) conference

-- Abstract compares relative effects on cognitive function following sedation with Byfavo (remimazolam) for injection versus midazolam -- Abstract co...

August 30, 2023, 6:50 am

Cerevel therapeutics to present at morgan stanley 21st annual global healthcare conference

CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain...

August 29, 2023, 6:30 am

Promoting excellence in mental healthcare: evoke neuroscience announces inaugural scholarship program

NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) — Evoke neuroscience, a leading provider of clinical brain h...

August 24, 2023, 7:09 pm


Search within

Pages Search Results: